. Author manuscript; available in PMC: 2025 Aug 27.

Published in final edited form as: J Neurointerv Surg. 2021 Dec 14;14(12):1253–1257. doi: 10.1136/neurintsurg-2021-018239

Table 2:

Comparison of rCBF, increase in rCBF, pial collateral score and arterial arrival time, infarct volume and difference of predicted (estimate based on pial collateral score and time to imaging relative to MCAO) versus measured infarct volume between control and treatment groups.

Variable	Control (σ)	Sanguinate (σ)	Standard error	P	r²/χ²
Mean rCBF following intervention^*	0.34 (0.194)	0.715 (0.322)	0.10	0.0064^*	0.536
Mean increase in rCBF^†	0.0405 (0.150)	0.274 (0.134)	0.0537	0.0096^†	0.442
Median (quartiles) increase in pial score^‡	0 (1/0)	+1 (0/+1)	NA	0.0057^‡	7.63
Mean increase in arterial arrival time (s)^†	0.438 (0.561)	−0.314 (0.561)	0.212	0.0276^†	0.344
Measured infarct volume (mm³) ^*	4739 (4400)	2585 (2680)	777	0.0443^*	0.687
Predicted - measured infarct volume (mm³)^†	616 (1994)	4336 (2050)	765	0.0049^†	0.496

Least Squares Regression – r2 adjusted

^†

ANOVA

^‡

Wilcoxan Rank Sums